On Demand Access

Future of the Microbiome Summit 2021 On Demand

Thank you for your interest in the Future of the Microbiome 2021 Summit. Session recordings and PDFs of presenter slides (where made available) are below for you to access. A huge thank you to our Premier Sponsor Health Wright Products, Champion Sponsors AIDP, Inc. and Deerland Probiotics and Enzymes, Partner Sponsor Atlantia Food Clinical Trials and Media Partner MicrobiomePost. Because of their support, we’re able to provide this content for free to you. 

Building Tomorrow’s Microbiome Products: The Contract Manufacturer/Brand Relationship

Charles Budinoff, PhD, IFF and Mark Wright, Health Wright Products

Clinical Findings on Synergies Between Select Prebiotics

Jennifer Gu, PhD, AIDP

Innovative Prebiotic Mechanisms: The Science of Bacteriophage

 John Deaton, PhD, Deerland Probiotics & Enzymes

Gut Microbiome Pattern Reflects Healthy Aging and Predicts Survival in Humans

Nathan Price, PhD, Institute for Systems Biology & Onegevity Health

Microbiome Connections with Host Metabolism and Habitual Diet from 1,098 Deeply Phenotyped Individuals

Francesco Asnicar, PhD, University of Trento

Profiling Pathogens in the Preterm Gut Microbiota

Lindsay Hall, PhD, Technical University of Munich and Quadram Institute

No slides are available for this session. 

Profiling Pathogens in the Preterm Gut Microbiota

Lindsay Hall, PhD, Technical University of Munich and Quadram Institute

Fine Fiber Structure-Microbe Interactions: Implications for Gut Ecology and Precision and Population-Scale Nutrition

 Stephen Lindemann, PhD, Purdue University

Systems Ecology of the Gut-Brain Axis: The Example of Parkinson’s Disease

 Paul Wilmes, PhD,  University of Luxembourg

No slides are available for this session. 

Postbiotics: A New Chapter in the Gut and Human Health

Hariom Yadav, PhD, Wake Forest School of Medicine

Microbiome-Drug Interactions: New Opportunities for Microbiome Science

Francisco Guarner, MD, PhD

Future of Live Biotherapeutic Products: Challenges and Opportunities in Science and Regulation

Georges Rawadi, PhD, YSOPIA Bioscience; Joseph Simmons, Pharmabiotic Research Institute, Shiri Meshner, PhD, Biomica, Ltd.

No slides are available for this session. 

Personalization Strategies: Moving Beyond Microbiome Testing

Mariëtte Abrahams, PhD, RD, Qina and Maria Kardakova, RNutr, Atlas BioMed Group

Investment and Innovation: From Knowledge to Commercialization

Kara Bortone, JLABS; Jonathan Scheiman, PhD, FitBiomics; Denise Kelly, PhD, Seventure and Brendan Curran, PhD, APC 

Metagenomic Insights of the Infant Microbiome Community

David Kyle, PhD, Evolve BioSystems, Inc.